|
Originally published In Press as doi:10.1074/jbc.M101350200 on July 5, 2001
J. Biol. Chem., Vol. 276, Issue 35, 32506-32514, August 31, 2001
Molecular Mechanisms of Ceramide-mediated Telomerase Inhibition
in the A549 Human Lung Adenocarcinoma Cell Line*
Besim
Ogretmen §,
Jacqueline M.
Kraveka¶,
Deborah
Schady ,
Julnar
Usta ,
Yusuf A.
Hannun , and
Lina M.
Obeid**
From the Departments of Biochemistry and Molecular
Biology and ¶ Pediatrics, Division of Hematology/Oncology, and
** Medicine and Ralph H. Johnson Veteran Administration,
Medical University of South Carolina, Charleston, South Carolina 29425, and the Department of Biochemistry, American University of
Beirut, Beirut, Lebanon
This study was aimed at
identifying the molecular mechanisms by which ceramide inhibits
telomerase activity in the A549 human lung adenocarcinoma cell line.
C6-ceramide (20 µM) caused a
significant reduction of telomerase activity at 24 h as detected using the telomeric repeat amplification protocol,
and this inhibition correlated with decreased telomerase reverse
transcriptase (hTERT) protein. Semi-quantitative reverse
transcriptase-polymerase chain reaction (RT-PCR) and Northern blot
analyses showed that C6-ceramide significantly decreased
hTERT mRNA in a time-dependent manner. Electrophoretic mobility shift and supershift assays demonstrated that the binding activity of c-Myc transcription factor to the E-box sequence on the
hTERT promoter was inhibited in response to C6-ceramide at 24 h. These results were also confirmed by transient transfections of A549 cells with pGL3-Basic plasmid constructs containing the functional hTERT promoter and its E-box deleted sequences cloned upstream of a luciferase reporter gene. Further analysis using RT-PCR
and Western blotting showed that c-Myc protein but not its mRNA
levels were decreased in response to C6-ceramide at 24 h. The effects of ceramide on the c-Myc protein were shown to be due to
a reduction in half-life via increased ubiquitination. Similar results
were obtained by increased endogenous ceramide levels in response to
nontoxic concentrations of daunorubicin, resulting in the inhibition of
telomerase and c-Myc activities. Furthermore, the elevation of
endogenous ceramide by overexpression of bacterial sphingomyelinase
after transient transfections also induced the inhibition of telomerase
activity with concomitant decreased hTERT and c-Myc protein levels.
Taken together, these results show for the first time that both
exogenous and endogenous ceramides mediate the modulation of telomerase
activity via decreased hTERT promoter activity caused by rapid
proteolysis of the ubiquitin-conjugated c-Myc transcription factor.
*
This work was supported in part by research grants from the
Department of Energy through the Environmental Biosciences Program at
MUSC, American Cancer Society Grant IRG-97-151-01, and Department of
Defense, Coastal Carolina Program Project project number 2 at Hollings
Cancer Center (to B. O.), and National Institutes of Health Grants
CA87584 and GM43825 (to Y. A. H.) and AG16583 and AG12467 (to
L. M. O.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Medical University of
South Carolina, Dept. of Biochemistry and Molecular Biology, P. O. Box
250779, Charleston, SC 29425. Tel.: 843-876-5192; Fax: 843-876-5172;
E-mail: ogretmen@musc.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Mukhopadhyay, S. A. Saddoughi, P. Song, I. Sultan, S. Ponnusamy, C. E. Senkal, C. F. Snook, H. K. Arnold, R. C. Sears, Y. A. Hannun, et al.
Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling
FASEB J,
March 1, 2009;
23(3):
751 - 763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Wooten-Blanks, P. Song, C. E. Senkal, and B. Ogretmen
Mechanisms of ceramide-mediated repression of the human telomerase reverse transcriptase promoter via deacetylation of Sp3 by histone deacetylase 1
FASEB J,
October 1, 2007;
21(12):
3386 - 3397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Senkal, S. Ponnusamy, M. J. Rossi, K. Sundararaj, Z. Szulc, J. Bielawski, A. Bielawska, M. Meyer, B. Cobanoglu, S. Koybasi, et al.
Potent Antitumor Activity of a Novel Cationic Pyridinium-Ceramide Alone or in Combination with Gemcitabine against Human Head and Neck Squamous Cell Carcinomas in Vitro and in Vivo
J. Pharmacol. Exp. Ther.,
June 1, 2006;
317(3):
1188 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, N. Idamakanti, T. Arroyo, S. Thorne, T. Reid, S. Nichols, M. VanRoey, G. Colbern, N. Nguyen, O. Tam, et al.
Dual Promoter-Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models
Clin. Cancer Res.,
December 15, 2005;
11(24):
8845 - 8855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Rouquette-Jazdanian, A. Foussat, L. Lamy, C. Pelassy, P. Lagadec, J.-P. Breittmayer, and C. Aussel
Cholera Toxin B-Subunit Prevents Activation and Proliferation of Human CD4+ T Cells by Activation of a Neutral Sphingomyelinase in Lipid Rafts
J. Immunol.,
November 1, 2005;
175(9):
5637 - 5648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Beyne-Rauzy, N. Prade-Houdellier, C. Demur, C. Recher, J. Ayel, G. Laurent, and V. Mansat-De Mas
Tumor necrosis factor-{alpha} inhibits hTERT gene expression in human myeloid normal and leukemic cells
Blood,
November 1, 2005;
106(9):
3200 - 3205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Wooten and B. Ogretmen
Sp1/Sp3-dependent Regulation of Human Telomerase Reverse Transcriptase Promoter Activity by the Bioactive Sphingolipid Ceramide
J. Biol. Chem.,
August 12, 2005;
280(32):
28867 - 28876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Kurinna, C. C. Tsao, A. F. Nica, T. Jiffar, and P. P. Ruvolo
Ceramide Promotes Apoptosis in Lung Cancer-Derived A549 Cells by a Mechanism Involving c-Jun NH2-Terminal Kinase
Cancer Res.,
November 1, 2004;
64(21):
7852 - 7856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koybasi, C. E. Senkal, K. Sundararaj, S. Spassieva, J. Bielawski, W. Osta, T. A. Day, J. C. Jiang, S. M. Jazwinski, Y. A. Hannun, et al.
Defects in Cell Growth Regulation by C18:0-Ceramide and Longevity Assurance Gene 1 in Human Head and Neck Squamous Cell Carcinomas
J. Biol. Chem.,
October 22, 2004;
279(43):
44311 - 44319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Marchesini, W. Osta, J. Bielawski, C. Luberto, L. M. Obeid, and Y. A. Hannun
Role for Mammalian Neutral Sphingomyelinase 2 in Confluence-induced Growth Arrest of MCF7 Cells
J. Biol. Chem.,
June 11, 2004;
279(24):
25101 - 25111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Symolon, E. M. Schmelz, D. L. Dillehay, and A. H. Merrill Jr.
Dietary Soy Sphingolipids Suppress Tumorigenesis and Gene Expression in 1,2-Dimethylhydrazine-Treated CF1 Mice and ApcMin/+ Mice
J. Nutr.,
May 1, 2004;
134(5):
1157 - 1161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Sundararaj, R. E. Wood, S. Ponnusamy, A. M. Salas, Z. Szulc, A. Bielawska, L. M. Obeid, Y. A. Hannun, and B. Ogretmen
Rapid Shortening of Telomere Length in Response to Ceramide Involves the Inhibition of Telomere Binding Activity of Nuclear Glyceraldehyde-3-phosphate Dehydrogenase
J. Biol. Chem.,
February 13, 2004;
279(7):
6152 - 6162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Obeid and Y. A. Hannun
Ceramide, Stress, and a "LAG" in Aging
Sci. Aging Knowl. Environ.,
October 1, 2003;
2003(39):
pe27 - 27.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. Horikawa and J. C. Barrett
Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms
Carcinogenesis,
July 1, 2003;
24(7):
1167 - 1176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-J. Kroesen, S. Jacobs, B. J. Pettus, H. Sietsma, J. W. Kok, Y. A. Hannun, and L. F. M. H. de Leij
BcR-induced Apoptosis Involves Differential Regulation of C16 and C24-Ceramide Formation and Sphingolipid-dependent Activation of the Proteasome
J. Biol. Chem.,
April 18, 2003;
278(17):
14723 - 14731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Elmore, C. W. Rehder, X. Di, P. A. McChesney, C. K. Jackson-Cook, D. A. Gewirtz, and S. E. Holt
Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction
J. Biol. Chem.,
September 13, 2002;
277(38):
35509 - 35515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Wang, H. Liu, and P. J. Szaniszlo
Compensatory expression of five chitin synthase genes, a response to stress stimuli, in Wangiella (Exophiala) dermatitidis, a melanized fungal pathogen of humans
Microbiology,
September 1, 2002;
148(9):
2811 - 2817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. A. Hannun and L. M. Obeid
The Ceramide-centric Universe of Lipid-mediated Cell Regulation: Stress Encounters of the Lipid Kind
J. Biol. Chem.,
July 12, 2002;
277(29):
25847 - 25850.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-L. Mergny, J.-F. Riou, P. Mailliet, M.-P. Teulade-Fichou, and E. Gilson
Natural and pharmacological regulation of telomerase
Nucleic Acids Res.,
February 15, 2002;
30(4):
839 - 865.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|